MKMinseok S. Kim

Minseok S. Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Minseok S. Kim has a total of 194 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Front Cover: A Biomimetic 3D Human Skeletal Muscle Microtissue for Modeling Biological and Functional Hallmarks of Aging (Small Sci. 10/2026)

    by Sohae Yang, Jeong Sik Kong, Hyun Young Shin, Sung Chun Cho, Aseer Intisar, Min Young Kim, Yeong‐Jin Choi, Yun‐Il Lee, Dong‐Woo Cho, Minseok S. Kim

  • Open Access

    A Biomimetic 3D Human Skeletal Muscle Microtissue for Modeling Biological and Functional Hallmarks of Aging

    by Sohae Yang, Jeong Sik Kong, Hyun Young Shin, Sung Chun Cho, Aseer Intisar, Min Young Kim, Yeong‐Jin Choi, Yun‐Il Lee, Dong‐Woo Cho, Minseok S. Kim

    Skeletal muscle is one of the largest organs in the human body, playing a central role in mobility, metabolism, and endocrine regulation. The aging global population underscores the need to understand skeletal muscle aging, which is bottlenecked by the lack of in vitro models that recapitulate biological and functional features of aged human muscle as well as discrepancies between humans and animal models. Here, we present a 3D biomimetic aged skeletal muscle model using human primary skeletal muscle cells (SkMCs) embedded in a skeletal muscle‐derived decellularized extracellular matrix (dECM) scaffold. Constructs fabricated from aged and young SkMCs were systematically evaluated across structural, molecular, mitochondrial, calcium‐handling, and contractile readouts. Compared with young constructs, aged constructs recapitulated several aging‐associated biological and functional phenotypes, including smaller myotubes, altered myogenic and inflammatory marker expression, mitochondrial alterations, delayed calcium responses, and weakened contractile forces. This human‐relevant platform enables simultaneous assessment of biological and functional aspects of muscle aging and may serve as a translational tool to study mechanisms and screen therapies for age‐associated muscle disorders. This aligns with the FDA Modernization Act 2.0—which recognizes in vitro human systems as alternatives to animal testing—underscoring the practical relevance of this model.

  • Robust Isolation and Multiplexed Identification of Circulating Rare Cells via Continuous Centrifugal Microfluidics and Hydrogel Immunocytochemistry

    by Hyeong Jung Woo, Hyun Gyu Kang, Sohae Yang, Hyejin Song, Seoyoung Lee, Sun Min Lee, Jungmin Lee, Sun-Young Kong, Jae Young Joung, Hye Ryun Kim, et al.

    Circulating rare cells (CRCs), including circulating tumor cells (CTCs) and circulating cancer-associated fibroblasts (cCAFs), are promising biomarkers for cancer diagnosis and prognosis. However, their extremely low abundance and phenotypic heterogeneity make efficient isolation and multiparametric analysis technically challenging. Here, we present a continuous centrifugal microfluidic workflow for the sequential isolation and identification of CRCs from whole blood. The cartridge comprises five interconnected chambers with controllable valves that enable precise handling of density gradient medium and blood layers during centrifugation. Based on a previously validated enrichment platform, the present workflow integrates hydrogel-based cell immobilization with multiplexed immunocytochemistry to support the downstream identification and characterization of multiple CRC subtypes, including CTCs and cCAFs. Following isolation, cells are immobilized within a hydrogel matrix to support cell retention during repeated immunostaining and imaging-based analysis. Using this workflow, both CTCs and cCAFs were identified from the same sample, demonstrating the feasibility of integrated analysis of multiple circulating rare-cell populations within a single liquid-biopsy workflow. This platform provides a practical and reproducible approach for downstream rare-cell characterization in liquid biopsy applications.

  • Open Access

    Synergistic Electroceutical-Glucocorticoid Intervention Mitigates Dexamethasone-Induced Muscle Atrophy in Aging Skeletal Muscle

    by Min Young Kim, Sohae Yang, Jeongmin Kim, Yongkoo Lee, Minseok S. Kim

    Dexamethasone (DEX), a synthetic glucocorticoid widely prescribed for allergic and inflammatory diseases, is known to induce adverse effects, particularly skeletal muscle atrophy. DEX-induced atrophy exacerbates sarcopenia and has a more pronounced impact on aged skeletal muscle than on young skeletal muscle. To address this unmet clinical need, we introduce an electroceutical approach that counteracts DEX-induced muscle atrophy and enhances functional recovery in aging muscle. When applied to both young and aged human-derived skeletal muscle cells (skMCs) exhibiting DEX-induced atrophy, electroceutical treatment promoted recovery of myotube diameter and upregulated hypertrophy-related gene expression. Furthermore, in a preclinical study, young and aged mice treated with DEX to induce muscle atrophy exhibited significant muscle recovery following electroceutical treatment. This effect was evident from the restored cross-sectional area (CSA) of type IIA muscle fibers and the upregulation of hypertrophy-related genes. This study highlights electroceuticals as a pioneering non-pharmacological strategy complementary to glucocorticoid therapies, potentially transforming clinical outcomes and quality of life, particularly for older populations vulnerable to muscle wasting.

  • Open Access

    Anti-Buoyancy Trap for Long-Term Quantitative Density Profiling of Adipocyte Spheroids

    by Min Young Kim, Sohae Yang, Minseok S. Kim

    3T3-L1 adipocyte spheroids are widely used three-dimensional adipose models that undergo pronounced physical property changes during adipogenic maturation, including progressive buoyancy driven by lipid accumulation. We quantitatively profiled the time-resolved evolution of bulk spheroid density over 60 days, revealing a 6.7% reduction from 1.022 to 0.954 g/cm3 associated with intracellular lipid accumulation. This buoyancy-driven displacement hinders standardized interrogation of spheroid physical properties during long-term culture. To enable longitudinal and reproducible analysis of density remodeling, we introduced an anti-buoyancy spheroid trap (AS-Trap) that mechanically stabilizes spheroids during extended culture. Morphometric analysis revealed that lipid droplet areas in mature spheroids (790.68±513.84 μm²) closely approximated in vivo adipocytes (846.34±257.28 μm²) and were substantially larger than those in 2D cultures, providing structural context for the observed density reduction. Notably, the terminal spheroid density converged toward reported values for native white adipose tissue, underscoring the physiological relevance of the material state achieved during maturation. Together, this work establishes density as a quantitative physical phenotype of adipogenic maturation and enables standardized long-term interrogation of adipose spheroids as living materials.

  • Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer

    by Hyeong Jung Woo, Paul N. Rademacher, Hyun Young Shin, Jungmin Lee, Aseer Intisar, Majid E. Warkiani, Jae Young Joung, Alexey Rzhevskiy, Cornelia Coith, Frederike Harten, et al.

    Circulating tumor cells (CTCs) are a key biomarker in cancer diagnostics, offering critical insights into metastasis and treatment responses. Although several automated CTC isolation systems have been developed, a thorough comparison of their performance with diverse cell types remains lacking. In addition to CTCs, simultaneous tumor microenvironment (TME) analysis can be valuable for formulating cancer treatment strategies. This includes investigating circulating cancer-associated fibroblasts (cCAFs), which offer a minimally invasive, real-time status of the TME, enabling frequent monitoring of cancer metastasis and treatment response. However, the automated and simultaneous isolation of CTCs and cCAFs has been unexplored. This research systematically evaluated the performance of FDA-registered automated CTC isolation systems with cancer cells of heterogeneous phenotypes, a breast cancer CTC cell line, as well as clinical samples from 27 breast cancer patients. The continuous centrifugal microfluidic system (CTCeptor) demonstrated superior recovery rates and enriched CTCs with broader size and surface marker heterogeneity compared to other positive selection-based technologies, isolating significantly more CTCs from the blood of cancer patients and achieving high detection rates. Notably, since the system relies on an unbiased isolation method, it also isolated cCAFs from patient blood, which were detected at frequencies 10 times higher than CTCs in early-stage breast cancer patients. For the first time, this study identified key CAF markers, highlighting the potential of cCAFs as a biomarker for early diagnosis and prognosis. The ability of this automated system to efficiently isolate both CTCs and cCAFs represents a significant advancement in liquid biopsy and precision oncology.


  • Open Access

    BCL6 coordinates muscle mass homeostasis with nutritional states

    by Hui J. Wang, Weiwei Fan, Sihao Liu, Kyeongkyu Kim, Ayami Matsushima, Satoshi Ogawa, Hyun Gyu Kang, Jonathan Zhu, Gabriela Estepa, Mingxiao He, et al.

    Nutritional status is a determining factor for growth during development and homeostatic maintenance in adulthood. In the context of muscle, growth hormone (GH) coordinates growth with nutritional status; however, the detailed mechanisms remain to be fully elucidated. Here, we show that the transcriptional repressor B cell lymphoma 6 (BCL6) maintains muscle mass by sustaining GH action. Muscle-specific genetic deletion of BCL6 at either perinatal or adult stages profoundly reduces muscle mass and compromises muscle strength. Conversely, muscle-directed viral overexpression of BCL6 significantly reverses the loss of muscle mass and strength. Mechanistically, we show that BCL6 transcriptionally represses the suppressor of cytokine signaling 2 to sustain the anabolic actions of GH in muscle. Additionally, we find that GH itself transcriptionally inhibits BCL6 through the Janus kinase and signal transducer and activator of transcription 5 (JAK/STAT5) pathway. Supporting the physiologic relevance of this feedback regulation, we show the coordinated suppression of muscle Bcl6 expression with the induction of GH in the fasted state. These findings reveal the complexity of the feedback controls modulating GH signaling and identify BCL6 as a key homeostatic regulator coordinating muscle mass with nutrient availability. Moreover, these studies open avenues for targeted therapeutic strategies to combat muscle-wasting conditions.


  • Open Access

    Quantitative analysis of the dexamethasone side effect on human-derived young and aged skeletal muscle by myotube and nuclei segmentation using deep learning

    by Seonghwan Park, Min Young Kim, Jaewon Jeong, Sohae Yang, Minseok S Kim, Inkyu Moon

    Motivation: Skeletal muscle cells (skMCs) combine together to create long, multi-nucleated structures called myotubes. By studying the size, length, and number of nuclei in these myotubes, we can gain a deeper understanding of skeletal muscle development. However, human experimenters may often derive unreliable results owing to the unusual shape of the myotube, which causes significant measurement variability. Results: We propose a new method for quantitative analysis of the dexamethasone side effect on human-derived young and aged skeletal muscle by simultaneous myotube and nuclei segmentation using deep learning combined with post-processing techniques. The deep learning model outputs myotube semantic segmentation, nuclei semantic segmentation, and nuclei center, and post-processing applies a watershed algorithm to accurately distinguish overlapped nuclei and identify myotube branches through skeletonization. To evaluate the performance of the model, the myotube diameter and the number of nuclei were calculated from the generated segmented images and compared with the results calculated by human experimenters. In particular, the proposed model produced outstanding outcomes when comparing human-derived primary young and aged skMCs treated with dexamethasone. The proposed standardized and consistent automated image segmentation system for myotubes is expected to help streamline the drug-development process for skeletal muscle diseases. Availability and implementation: The code and the data are available at https://github.com/tdn02007/QA-skMCs-Seg


  • Open Access

    Utility and Clinical Value of Circulating Tumor Cells in Gastrointestinal Cancer

    by Hyeongjung Woo, Hyun Young Shin, Minseok S. Kim

    Hyeongjung Woo, Hyun Young Shin, Minseok S. Kim. Journal of Digestive Cancer Research 2024;12:106-14. https://doi.org/10.52927/jdcr.2024.12.2.106

  • Open Access

    Double‐Sided, Thin‐Film Microelectrode Array with Hemispheric Electrodes for Subretinal Stimulation

    by Namju Kim, Yeji Hong, Seongkwang Cha, Yoo Na Kang, Hee Won Seo, Hyunmin Moon, Jungryul Ahn, Aseer Intisar, Minseok S. Kim, Seong‐Woo Kim, et al.

    Components in neural implants, such as the electrode array and stimulator circuit, are often fabricated discretely. This modular fabrication scheme offers flexibility during development but poses difficulties during assembly, as components must be compactly integrated for implantation. It is particularly difficult in cases where the electrode array is required to have a high number of channels, such as in retinal prostheses. This paper presents the development of a parylene C‐based, double‐sided microelectrode array with 294 hemispheric electrodes for subretinal stimulation. The bonding pads on the bottom side of the double‐sided array are connected with electrodes through vias, eliminating the interconnection lines. The array can be integrated with a stimulator circuit through pad‐to‐pad bonding, resulting in a compact implant. The hemispheric electrodes are fabricated using thermally reflowed photoresist infillings, through which the height and width of the hemispheres can be easily controlled. The long‐term stability and biocompatibility of the materials and methods used to fabricate and package the electrodes are demonstrated in in vitro and in vivo environments over months. Finally, subretinal stimulation by the developed electrodes is successfully demonstrated using in vitro retinal patches from mice and monkeys.